Citation Impact
Citing Papers
Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin.
2008
Prevalence of burnout syndrome in oncology nursing: A meta‐analytic study
2018
Acute Hepatitis C Virus in an HIV Clinic: A Screening Strategy, Risk Factors, and Perception of Risk
2011
Hepatitis C viral load, genotype, and increased risk of developing end‐stage renal disease: REVEAL‐HCV study
2017
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
2002
Assessment of the prognosis of cirrhosis: Child–Pugh versus MELD
2004
The Second Canadian Symposium on Hepatitis C Virus: A Call to Action
2013 StandoutNobel
Acute hepatitis C and HIV coinfection
2009
Hepatic stellate cells as key target in liver fibrosis
2017
The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report
2009
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs)
2009
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
Hepatocellular carcinoma
2016 Standout
Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
2010
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Burden of liver diseases in the world
2018 Standout
Alcoholic liver disease: mechanisms of injury and targeted treatment
2015
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Hepatocellular carcinoma
2012 Standout
Hepatocellular carcinoma
2021 Standout
Clinical Course of Alcoholic Liver Cirrhosis: A Danish Population-Based Cohort Study
2009
HIV/HCV Co-infection: Pathogenesis, Clinical Complications, Treatment, and New Therapeutic Technologies
2011
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis
2016
Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
2013
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Portal hypertensive bleeding in cirrhosis
2016 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Chronic hepatitis B
2007 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe
2016
Global burden of liver disease: 2023 update
2023 Standout
Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study
2015
Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
2015
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
2010 Standout
Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels
2013
Burnout and its relationship with personality factors in oncology nurses
2017
Hepatitis C Virus Infections in the Swiss HIV Cohort Study: A Rapidly Evolving Epidemic
2012
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Long-term Clinical Course of Decompensated Alcoholic Cirrhosis
2011
Long‐term prognosis of patients with alcoholic liver cirrhosis: a 15‐year follow‐up study of 100 Norwegian patients admitted to one unit
2004
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Mortality in Hepatitis C Virus-Infected Patients With a Diagnosis of AIDS in the Era of Combination Antiretroviral Therapy
2012
NAFLD: A multisystem disease
2015 Standout
Alcoholic Liver Disease
2009
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine
2012
The burden of liver disease in Europe: A review of available epidemiological data
2013
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial
2015
Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation
2011
Biomarkers of Inflammation and Coagulation Are Associated With Mortality and Hepatitis Flares in Persons Coinfected With HIV and Hepatitis Viruses
2013
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
2015 StandoutNobel
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
2018
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Prevalence of burnout in mental health nurses and related factors: a systematic review and meta‐analysis
2019 Standout
Challenges, successes and patterns of enrolment in the INSIGHT S trategic T iming of AntiRetroviral T reatment (START ) trial
2015
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Hepatitis C virus NS 3/4A quasispecies diversity in acute hepatitis C infection in HIV ‐1 co‐infected patients
2014
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
2009
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study
2017
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
2014 StandoutNobel
Guidelines for the management of hemophilia
2012 Standout
Levels of Burnout and Risk Factors in Medical Area Nurses: A Meta-Analytic Study
2018
Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub‐Saharan Africa: Systematic review and meta‐analysis
2020
Works of Lars Peters being referenced
HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective
2014
Five‐year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence
2003
Epidemiology of hepatitis C virus in HIV-infected patients
2015
Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus–coinfected Individuals From 2001 to 2014: A Multicohort Study
2016
How Death Anxiety Impacts Nurses’ Caring for Patients at the End of Life: A Review of Literature
2013
Hepatitis C Virus Coinfection Does Not Influence the CD4 Cell Recovery in HIV-1-Infected Patients With Maximum Virologic Suppression
2009
Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in HIV‐Infected Patients with Anti‐HCV Antibodies in Europe
2008
Hepatitis delta in HIV-infected individuals in Europe
2011
Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
2013
Opportunistic Disease and Mortality in Patients Coinfected with Hepatitis B or C Virus in the Strategic Management of Antiretroviral Therapy (SMART) Study
2008
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adults
2008
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients
2012
Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies
2019
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA
2013
Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?
2015
Baseline prevalence and predictors of liver fibrosis amongHIV ‐positive individuals: a substudy of theINSIGHT Strategic Timing of AntiRetroviral Treatment (START ) trial
2015